Clinical trialNCT05952804RecruitingPhase 2Interventional

IVIG for Infection Prevention After CAR-T-Cell Therapy

SponsorFred Hutchinson Cancer CenterEnrollment150Hematologic Malignancies

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Joshua Hill, MD
Fred Hutch/University of Washington Cancer Consortium
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

City of Hope Cancer Center
Duarte, California, United States
Sanjeet Dadwal, MD
Recruiting
University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
Jay Spiegel, MD
Recruiting
Moffitt Cancer Center
Tampa, Florida, United States
Frederick Locke, MD
Recruiting
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
Matthew Frigault, MD
Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Miguel-Angel Perales, MD
Recruiting
Oregon Health and Science University (ohsu) Knight Cancer Institute
Portland, Oregon, United States
Amrita Desai, MD, MPH
Recruiting
Fred Hutch/university of Washington Cancer Consortium
Seattle, Washington, United States
Joshua Hill, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 10 Jun 2024
Primary completion: 31 Jul 2028
Completion: 31 Jul 2028
Last update posted: 29 Jun 2026
Registered enrollment: 150
Registry id: NCT05952804

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.